J7169
HCPCSInj andexxa, 10 mg
Official HCPCS Level II long descriptor
Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
HCPCS Level II code J7169 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj andexxa, 10 mg
Added to HCPCS: 2020-07-01
Nearby codes in J7
- J7070D5w infusion
- J7100Dextran 40 infusion
- J7110Dextran 75 infusion
- J7120Ringers lactate infusion
- J71215% dextrose in lac ringers
- J7131Hypertonic saline sol
- J7165Inj, human-lans, per i.u
- J7168Prothrombin complex kcentra
- J7170Inj., emicizumab-kxwh 0.5 mg
- J7171Inj, adzynma, 10 iu
- J7172Inj marstacim-hncq, 0.5 mg
- J7173Inj. concizumab-mtci, 0.5 mg
- J7174Injection fitusiran 0.04 mg
- J7175Inj, factor x, (human), 1iu
- J7176Inj. fesilty, 1 mg
- J7177Inj., fibryga, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.